ENTX News and Press, Entera Bio Ltd.

TEL AVIV, May 28, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that multiple abstracts across its oral peptide pipeline have been accepted for presentation at ENDO 202...

2026-05-11 02:44:33 ET More on Entera Bio Entera Bio Ltd. (ENTX) Discusses Osteoporosis Treatment Landscape and Clinical Potential of EB613 Oral Tablet Transcript Entera Bio prices $10M direct investment, sees up to $24.5M in total proceeds Seeking Alpha’s Qua...

EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis – Phase 3 protocol submitted with FDA feedback expected imminently; incremental data submitted to ENDO2026 and ASBMR EB612, the first oral long-acting PTH peptide replacement table...

2026-04-20 13:21:44 ET Entera Bio Ltd. (ENTX) Discusses Osteoporosis Treatment Landscape and Clinical Potential of EB613 Oral Tablet April 20, 2026 11:00 AM EDT... Read the full article on Seeking Alpha For further details see: Entera Bio Ltd. (ENTX) Discusses Osteoporosis T...

In a virtual Key Opinion Leader (KOL) roundtable hosted today, Entera Bio (Nasdaq: ENTX) convened globally recognized authorities in osteoporosis and women's health to discuss the current osteoporosis treatment landscape and the opportunity for its lead clinical candidate, EB613 - being developed...

TEL AVIV, Israel, April 14, 2026 (GLOBE NEWSWIRE) -- TEL AVIV, Israel, April 14, 2026 -- Entera Bio Ltd. (Nasdaq: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced it will host a virtual Key Opinion Leader (KOL) webinar fo...

Greenberg Traurig Represents Israel-based Entera Bio in $10M Private Placement Led by BVF Partners PR Newswire MIAMI , April 6, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, P.A.  advised Israel-based Entera Bio Ltd. (Nasdaq: ENTX), a clinical-stage biotechnology ...

2026-04-02 08:59:38 ET More on Entera Bio Seeking Alpha’s Quant Rating on Entera Bio Historical earnings data for Entera Bio Financial information for Entera Bio Read the full article on Seeking Alpha For further details see: Entera Bio pri...

TEL AVIV, Israel, April 02, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (Nasdaq: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that it has entered into a securities purchase agreement for a private placement (the “...

2026-03-27 16:30:49 ET More on Entera Bio Seeking Alpha’s Quant Rating on Entera Bio Historical earnings data for Entera Bio Financial information for Entera Bio Read the full article on Seeking Alpha For further details see: Entera Bio GAA...